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Conclusions: Electrocardiographic abnormalities in this population are domi-
nated by repolarisation, conduction defects and left ventricular hypertrophy, and
are more related to blood pressure indices than diabetes specific factors.
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Purpose: In a large contemporary non experimental cohort of patients (pts)
with known CAD, we assessed long term prognosis associated with statin therapy.
Methods: 783 consecutive male pts hospitalized in 2001-2004 for coro-
nary artery disease were considered. The median follow-up was 7.17 years.
Total mortality was predicted with a Cox proportional hazard model.
Results: Mean age (SD) was 60.2 (8.1), 144 pts (18.4%) were diabetic, mean
glycaemia was 5.9 mmol/l (2.1), 155 pts (19.8%) were smokers, mean blood pres-
sure was 139 (20) / 84 (11) mmHg and median heart rate was 61 bpm [Interquatile
range (IQR)] [57-70]. Mean HDL cholesterol was 43 mg/dl (11), mean LDL cho-
lesterol 124 mg/dl (39) and median triglycerides were 147 mg/dl IQR [109-197].
Mean Cockcroft-Gault creatinine clearance was 87 ml/min and 11 pts (1.4%) had
a severe chronic renal failure (lower than 30 ml/min). Mean left ventricular ejec-
tion fraction was 0.53 (0.13). 88.5% were on antiplatelet therapy, 75.2% on beta-
blocker, and 54.8% on ACE inhibitors or ARB.
Statin therapy was given to 507 pts (66%). The cumulative seven-year total
mortality rate was 17.9% in the whole sample. It was 14.1% in the statin
group but reached 25.2% in pts without statin therapy (p<0.001.).
After multivariate adjustment for age, diabetes, tobacco consumption (none ;
40 pack-years; >40 pack-years), heart rate, left ventricular ejection fraction (>0.5;
0.5 and >0.35; 0.35), duration of CAD, ankle-brachial index (>0.9; 0.9 and
>0.6; 0.6), history of chronic obstructive pulmonary disease or stroke and coro-
nary revascularization, all-cause death was reduced by 46% (95% CI [23%; 63%]
p=0.001) in the group with statin therapy compared to the group without.
Conclusion: In this large observational cohort of non-selected coronary
pts, risk of all-cause death is decreased by more than 50% in pts under statin
therapy.
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Background: Epidemiological studies data indicate that the incidence of
AF, a rapidly growing epidemic burden, varies from 10 to 20 per 1000 person-
years in subjects aged 65 or over. Age is the more potent AF risk factor, due
to combined risk factors and/or predisposing cardiac conditions for AF.
Aims: We aimed to evaluate the clinical and ECG predictors of the inci-
dence of AF in a large contemporary French population-based prospective
cohort study. The clinical evaluation and ECG was realized at admission and
after 4 years of follow-up.
Methods: The study is part of the Three City Study (COVADIS), which
included subjects aged - 65 years and not institutionalised. The incidence was
investigated during a mean follow-up period of 3.65 years.
Results: The overall incidence rate was 4.4/1000 persons per years. Based
on multivariable analyses, the HR was 2.32 [95% CI: 1.41-4.00], p<0.001) for
male gender. Age above 75 years (HR 2.34 [CI 95%: 1.21-4.74], p=0.015),
hypertension (HR 1.84 [95% CI: 1.10-3.10], p=0,02) and history of AF (HR
3.34 [95% CI: 1.12-8.89], p=0.03) were associated with an increased incidence
of AF. ECG-derived parameters, including LV hypertrophy, and the usual clin-
ical risk markers were not associated with AFoccurrence at follow-up.
Conclusion: In a contemporary cohort of elderly subjects, hypertension,
age, history of previous AF and gender are predictors of AF occurrence at
midterm follow-up. No ECG variables were predictors of AF. 
320
Relationship between uric acid and metabolic syndrome in non-diabe-
tic and non-hypertensive in a Tunisian population
Wiem Zidi (1), Monia Elasmi [Orateur] (2), Yosra Zayani (1), Moncef
Feki (1), Riadh Jemaa (1), Heifa Sanhaji (1), Sameh Hadj Taieb (1), Sou-
heil Omar (1), Abderraouf Mebazaa (1)
(1) CHU la Rabta, Research Laboratory LR99ES11, Biochemistry Labo-
ratory, Tunis, Tunisia – (2) CHU la Rabta, Laboratoire de Biochimie ,
Tunis, Tunisie
Objective: Serum uric acid (UA) is reported as an important marker of
hypertension, coronary heart disease, and diabetes. We examined the associa-
tion of serum uric acid (UA) with metabolic syndrome (MS) in a Tunisian
population.
Materiel and methods: The study included 2712 subjects (1228 men and
1484 women), aged from 35 to 70 years and living in the Great Tunis region.
Patients with a history of CVD and Chronic Kidney disease (CKD) were
excluded from the study. The MS was defined according toATPIII. Hyperuri-
cemia was defined as a serum UA value >7.0 mg/dL for males or >6.0 mg/dL
for females.
Results: The prevalence of hyperuricemia, and metabolic syndrome, were
6.1% (9.8% in men and 2.8% in women), and 12.8% (10.2% in men and
15.2% in women), respectively.
Serum uric acid concentrations were significantly and positively correlated
with body mass index, diastolic blood pressure and serum triglyceride concen-
trations; and statistically significant and inverse correlations were noted for
serum uric acid and serum HDL-C concentrations. The prevalence of MS
increased in men and in women according to the quartile of serum uric acid
(p<0.0001). After adjusting for age, smoking status and BMI, multivariate
logistic regression analysis revealed that there was a significant association
between third-quartile uric acid levels and prevalence of metabolic syndrome
in men and in women.
Conclusion: An increase of uric acid constitutes a risk factor for metabolic
syndrome in Tunisian population. Uric acid may be a useful index for initial
risk stratification of patient non-diabetic non hypertensive.
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Abstract: The present study aimed to determine the prevalence of pre-
hypertension (preHTN) and its cardio-metabolic profile in Tunisians, and to
estimate the risk for coronary heart disease (CHD) according to blood pressure
status. A total of 2712 individuals, aged 35 to 69 years were included. The
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prevalence of preHTN and HTN was 56.8% and 25.0% in males, and 43.1%
and 36.1% in females, respectively. Subjects with preHTN and those with
HTN showed higher prevalence of diabetes, dyslipidemia, obesity and abdom-
inal obesity than the normotensive (NT) group. The risk of developing CHD
within 10 years was above 15% for 3.9%, 31.1% and 65.0% among NT,
preHTN and HTN subjects, respectively. In multivariate analysis, preHTN
was associated with age, male gender, obesity, abdominal obesity and
smoking. In total, preHTN is very common in Tunisians. It is associated with
a higher prevalence of cardio-metabolic risk factors and confers a higher risk
for subsequent CHD. These findings support the recommendations of lifestyle
modification for preHTN patients.
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Objective: It has been shown that blood levels of Lipoprotein-associated
phospholipase A2 (Lp-PLA2) predict future cardiovascular events regarding
the presence of any other traditional cardiovascular (CV) risk factors except
LDL-Cholesterol (LDL-C). The aim of our study was to assess possible links
between Lp-PLA2 and LDL and HDL subclasses.
Methods: Overweighed and obese patients with no history of cardiovas-
cular disease were recruited at our outpatient clinic and all underwent routine
clinical and biological evaluation, as well as LDL and HDL subclasses deter-
mination. None was under any lipid lowering treatment. Lp-PLA2 was mea-
sured in serum with a Plac test turbidimetric immunoassay.
Results: 49 patients were included. Mean body mass index was
31.84kg/m² (sd: 3.45). The Lp-PLA2 ranged from 41 to 407 ng/mL; mean
value was 201 ng/mL (sd: 73). Mean values for total cholesterol, LDL-C,
HDL-C and apoB were respectively 2.31 g/L (sd: 0.38), 1.39 g/L (sd: 0.32),
0.47 g/L (sd: 0.13), and 1.27 g/L (sd: 0.25). 18 patients (37%) had dia-
betes. Mean HDL2b percentage was 11.47% (sd: 7.48). Mean HDL3b per-
centage was 27.22 % (sd: 9.22). In univariate analysis, we found a strong
linear correlation between Lp-PLA2, and LDL-C (r=0.42, p<0.028) as well
as apoB (r=0.31, p=0.02) and total cholesterol (r=0.44, p=0.001). There
was no correlation between percentages of LDL subclasses (LDL 1,2,3 and
4) or LDL size peak and Lp-PLA2 levels. We found no correlation with
total HDL-C but a positive correlation with HDL2b percentage (r=0.29,
p=0.04) and a negative association with HDL3b percentage (r=–0.3,
p=0.03). Neither ApoA1 (r=0.061) nor ApoA2 (r=0.059) were correlated
with Lp-PLA2 dosages. 
Conclusion: In our population, LpPLA2 was related with total LDL-C
levels without any significant relation with the LDL subclasses distribu-
tion. By contrast, LpPLA2 was not correlated with HDL-C level but with
HDL subclasses. Interestingly, LpPLA2 was negatively correlated with
HDL3b and positively with large HDL particles (HDL2b). This supports
differential properties of HDL subclasses in atherosclerosis and suggests a
potential interaction between HDL and LpPLA2.
